Halocarbon Hires Two Industry Veterans for Sales and Marketing

Written by Halocarbon Staff on . Posted in News, Press Releases

ATLANTA – May 29, 2016 – Halocarbon Products Corporation, a leading worldwide producer of specialty fluorochemicals, inhalation anesthetics, and inert lubricants, today announced the hiring of two industry veterans: Dr. Siddhartha Shenoy as Director of Strategic Marketing, and Matt Muller as Senior Sales Manager of Oils, Greases and Waxes.

Halocarbon Appoints David Bacon New Chief Executive Officer

Written by Halocarbon Staff on . Posted in Press Releases

DAVID-BACONRIVER EDGE, N.J. – April 15, 2015 – Halocarbon Products Corporation, a leading worldwide producer of specialty fluorochemicals and inhalation anesthetics, today announced that David Bacon will be joining the company as its new chief executive officer, effective April 28, 2015.

Bacon, 46, joins Halocarbon with more than 24 years of experience in market analysis and driving innovation. As Halocarbon’s new CEO, Bacon’s top priorities will be leading the next phase of the company’s growth and product innovation.

Halocarbon Expertise Yields Profits

Written by Halocarbon Staff on . Posted in Press Releases

Halocarbon (River Edge, NJ) has carved out a profitable niche in fluorine chemistry, leveraging 60 years of expertise to build positions in specialty fluorochemicals, inhalation anesthetics, and inert oils, waxes, and greases. The privately held company does not disclose sales, but says revenues are in the tens of millions of dollars per year. Growth has been strong, at 20% in 2010, due to the addition of new chemistries, and early indications show the company is on track to post similar results for full-year 2011. Fluorochemicals make up about half of Halocarbon’s sales, with anesthetics and oils, greases, and waxes accounting for the remaining 30% and 20%, respectively. Exports accounted for just under 60% of the company’s revenue last year.

Contract Fine Chemical Firms Upbeat, but Questions Arise Over Long-Term Market Outlook

Written by Halocarbon Staff on . Posted in Press Releases

Several key manufacturers of active pharmaceutical ingredients (API) and pharmaceutical intermediates interviewed by CW at the CPhI show in Frankfurt today say that the market is buoyant and they are continuing to grow their businesses. The heads of Sigma Aldrich Fine Chemicals (SAFC) and Carbogen-Amis warn, however, that with billions of dollars of sales of innovator pharmaceuticals about to come off patent in 2012 the contract manufacturing sector could be about to face a period of consolidation.

U.S. Fluorochemicals Firm Halocarbon Optimistic on Growth

Written by Halocarbon Staff on . Posted in Press Releases

Halocarbon (River Edge, NJ), a privately owned fluorochemicals manufacturer for the fine and specialty chemicals sectors, hasdisclosed strong financial results for its fiscal year in 2011 and says it is optimistic for its prospects in 2012. “We’re expectinganother year of double-digit growth,” says Halocarbon CEO Peter Murin.

Worldwide supply of hexafluoroisopropanol (HFIP), a compound used in photoresists for semiconductor manufacturing as well asin the anesthetic sevoflurane, is very tight. To meet the increase in demand Halocarbon has upgraded its plant to increasecapacity and “fill the void,” the company says.

Halocarbon Expertise Yields Profits

Written by Halocarbon Staff on . Posted in Press Releases

Halocarbon (River Edge, NJ) has carved out a profitable niche in fluorine chemistry, leveraging 60 years of expertise to build positions in specialty fluorochemicals, inhalation anesthetics, and inert oils, waxes, and greases. The privately held company does not disclose sales, but says revenues are in the tens of millions of dollars per year. Growth has been strong, at 20% in 2010, due to the addition of new chemistries, and early indications show the company is on track to post similar results for full-year 2011. Fluorochemicals make up about half of Halocarbon’s sales, with anesthetics and oils, greases, and waxes accounting for the remaining 30% and 20%, respectively. Exports accounted for just under 60% of the company’s revenue last year.